Rory Collins

Sir Rory Collins
Born Rory Edwards Collins
(1955-01-03) 3 January 1955[1]
Hong Kong[1]
Fields
Institutions University of Oxford
Alma mater
Known for UK Biobank[2][3][4]
Notable awards
Website
www.ndph.ox.ac.uk/team/rory-collins

Sir Rory Edwards Collins (born 1955) FMedSci FRS[5] is Professor of Medicine and Epidemiology at the Clinical Trial Service Unit within the University of Oxford and a Fellow of Green Templeton College, Oxford. His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer, while also being closely involved in developing approaches to the combination of results from related studies ("meta-analyses").[6][7][8]

Education

Collins was educated at Dulwich College[1] and studied Medicine at St Thomas's Hospital Medical School, part of the University of London (1974-1980), and Statistics at George Washington University from 1976 to 1977 and the University of Oxford from 1982 to 1983.

Career and research

Since 1985, Collins has been co-director with Sir Richard Peto of the University of Oxford's Clinical Trial Services and Epidemiological Studies units. In 1996, he was appointed Professor of Medicine and Epidemiology at Oxford, supported by the British Heart Foundation. Since September 2005, he has also been acting as the Principal Investigator and Chief Executive of the UK Biobank,[2][3][4] in particular regarding the prospective study of 500,000 British people, aged 40–69.

Collins' work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer.[9]

He has created and led large studies that transformed statins from esoteric drugs for familial hypercholesterolaemia into widely used generics that reportedly prevent millions of heart attacks and ischaemic strokes annually. His large placebo-controlled trials and worldwide Cholesterol Treatment Trialists’ meta-analyses confirmed heart attack reduction, discovered stroke reduction, and demonstrated safety and efficacy in many different types of patient.[5] His research has been funded by the Medical Research Council (MRC).[10]

Awards and honours

Collins was knighted in the 2011 New Year Honours for services to science.[11] He was elected as a Fellow of the Academy of Medical Sciences in 2004 and a Fellow of the Royal Society (FRS) in 2015.[5]

References

  1. 1 2 3 COLLINS, Sir Rory (Edwards). Who's Who 2016 (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc. (subscription required)
  2. 1 2 Sudlow, Cathie; Gallacher, John; Allen, Naomi; Beral, Valerie; Burton, Paul; Danesh, John; Downey, Paul; Elliott, Paul; Green, Jane; Landray, Martin; Liu, Bette; Matthews, Paul; Ong, Giok; Pell, Jill; Silman, Alan; Young, Alan; Sprosen, Tim; Peakman, Tim; Collins, Rory (2015). "UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age". PLOS Medicine 12 (3): e1001779. doi:10.1371/journal.pmed.1001779. ISSN 1549-1676.
  3. 1 2 Allen, N. E.; Sudlow, C.; Peakman, T.; Collins, R. (2014). "UK Biobank Data: Come and Get It". Science Translational Medicine 6 (224): 224ed4–224ed4. doi:10.1126/scitranslmed.3008601. ISSN 1946-6234.
  4. 1 2 Collins, Rory (2012). "What makes UK Biobank special?". The Lancet 379 (9822): 1173–1174. doi:10.1016/S0140-6736(12)60404-8. ISSN 0140-6736.
  5. 1 2 3 4 "Sir Rory Collins FMedSci FRS". London: Royal Society. Archived from the original on 2015-11-17. One or more of the preceding sentences incorporates text from the royalsociety.org website where:
    “All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License.” --Royal Society Terms, conditions and policies at the Wayback Machine (archived September 25, 2015)
  6. ↑ Rory Collins's publications indexed by the Scopus bibliographic database, a service provided by Elsevier.
  7. ↑ Collaboration, A. T. (2002). "Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients". BMJ 324 (7329): 71–86. doi:10.1136/bmj.324.7329.71. ISSN 0959-8138.
  8. ↑ "MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial". The Lancet 360 (9326): 7–22. 2002. doi:10.1016/S0140-6736(02)09327-3. ISSN 0140-6736.
  9. ↑ Rory Collins' profile
  10. ↑ "UK government grants awarded to Rory Collins". Swindon: Research Councils UK. Archived from the original on 2015-12-18.
  11. ↑ The London Gazette: (Supplement) no. 59647. p. 1. 31 December 2010.


This article is issued from Wikipedia - version of the Saturday, April 16, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.